- Home
- CLLS vs LXFR Comparison
CLLS vs LXFR Comparison
Compare CLLS & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | LXFR |
|---|---|---|
| Founded | 1999 | 1898 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 459.5M |
| IPO Year | 2014 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CLLS | LXFR |
|---|---|---|
| Price | $1.25 | $17.24 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | 191.3K | ★ 366.1K |
| Earning Date | 11-06-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $384,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | $6.26 |
| P/E Ratio | ★ N/A | $55.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.22 | $11.26 |
| 52 Week High | $5.48 | $19.45 |
Technical Indicators
Market Signals| Indicator | CLLS | LXFR |
|---|---|---|
| Relative Strength Index (RSI) | 21.90 | 51.20 |
| Support Level | $1.25 | $17.19 |
| Resistance Level | $2.99 | $17.38 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 7.63 | 12.67 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.